Surgical Gloves Market (By Product: Neoprene, Nitrile, Natural Rubber, Polyisoprene, Others; By Sterility: Sterile Gloves, Non- Sterile Gloves; By Form: Powder-free, Powder; By End-use: Dental, Veterinary, Emergency medical service, Hospital, Others; By Usage: Reusable, Disposable) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Surgical Gloves Market 

5.1. COVID-19 Landscape: Surgical Gloves Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Surgical Gloves Market, By Product

8.1. Surgical Gloves Market Revenue and Volume, by Product, 2024-2033

8.1.1. Neoprene

8.1.1.1. Market Revenue and Volume Forecast (2021-2033)

8.1.2. Nitrile

8.1.2.1. Market Revenue and Volume Forecast (2021-2033)

8.1.3. Natural Rubber

8.1.3.1. Market Revenue and Volume Forecast (2021-2033)

8.1.4. Polyisoprene

8.1.4.1. Market Revenue and Volume Forecast (2021-2033)

8.1.5. Others

8.1.5.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 9. Global Surgical Gloves Market, By Sterility

9.1. Surgical Gloves Market Revenue and Volume, by Sterility, 2024-2033

9.1.1. Sterile Gloves

9.1.1.1. Market Revenue and Volume Forecast (2021-2033)

9.1.2. Non- Sterile Gloves

9.1.2.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 10. Global Surgical Gloves Market, By Form 

10.1. Surgical Gloves Market Revenue and Volume, by Form, 2024-2033

10.1.1. Powder-free

10.1.1.1. Market Revenue and Volume Forecast (2021-2033)

10.1.2. Powder

10.1.2.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 11. Global Surgical Gloves Market, By End-use

11.1. Surgical Gloves Market Revenue and Volume, by End-use, 2024-2033

11.1.1. Dental

11.1.1.1. Market Revenue and Volume Forecast (2021-2033)

11.1.2. Veterinary

11.1.2.1. Market Revenue and Volume Forecast (2021-2033)

11.1.3. Emergency medical service

11.1.3.1. Market Revenue and Volume Forecast (2021-2033)

11.1.4. Hospital

11.1.4.1. Market Revenue and Volume Forecast (2021-2033)

11.1.5. Others

11.1.5.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 12. Global Surgical Gloves Market, By Usage

12.1. Surgical Gloves Market Revenue and Volume, by Usage, 2024-2033

12.1.1. Reusable

12.1.1.1. Market Revenue and Volume Forecast (2021-2033)

12.1.2. Disposable

12.1.2.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 13. Global Surgical Gloves Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Volume Forecast, by Product (2021-2033)

13.1.2. Market Revenue and Volume Forecast, by Sterility (2021-2033)

13.1.3. Market Revenue and Volume Forecast, by Form (2021-2033)

13.1.4. Market Revenue and Volume Forecast, by End-use (2021-2033)

13.1.5. Market Revenue and Volume Forecast, by Usage (2021-2033)

13.1.6. U.S.

13.1.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)

13.1.6.2. Market Revenue and Volume Forecast, by Sterility (2021-2033)

13.1.6.3. Market Revenue and Volume Forecast, by Form (2021-2033)

13.1.6.4. Market Revenue and Volume Forecast, by End-use (2021-2033)

13.1.6.5. Market Revenue and Volume Forecast, by Usage (2021-2033) 

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Volume Forecast, by Product (2021-2033)

13.1.7.2. Market Revenue and Volume Forecast, by Sterility (2021-2033)

13.1.7.3. Market Revenue and Volume Forecast, by Form (2021-2033)

13.1.7.4. Market Revenue and Volume Forecast, by End-use (2021-2033)

13.1.7.5. Market Revenue and Volume Forecast, by Usage (2021-2033)

13.2. Europe

13.2.1. Market Revenue and Volume Forecast, by Product (2021-2033)

13.2.2. Market Revenue and Volume Forecast, by Sterility (2021-2033)

13.2.3. Market Revenue and Volume Forecast, by Form (2021-2033)

13.2.4. Market Revenue and Volume Forecast, by End-use (2021-2033) 

13.2.5. Market Revenue and Volume Forecast, by Usage (2021-2033) 

13.2.6. UK

13.2.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)

13.2.6.2. Market Revenue and Volume Forecast, by Sterility (2021-2033)

13.2.6.3. Market Revenue and Volume Forecast, by Form (2021-2033)

13.2.7. Market Revenue and Volume Forecast, by End-use (2021-2033) 

13.2.8. Market Revenue and Volume Forecast, by Usage (2021-2033) 

13.2.9. Germany

13.2.9.1. Market Revenue and Volume Forecast, by Product (2021-2033)

13.2.9.2. Market Revenue and Volume Forecast, by Sterility (2021-2033)

13.2.9.3. Market Revenue and Volume Forecast, by Form (2021-2033)

13.2.10. Market Revenue and Volume Forecast, by End-use (2021-2033)

13.2.11. Market Revenue and Volume Forecast, by Usage (2021-2033)

13.2.12. France

13.2.12.1. Market Revenue and Volume Forecast, by Product (2021-2033)

13.2.12.2. Market Revenue and Volume Forecast, by Sterility (2021-2033)

13.2.12.3. Market Revenue and Volume Forecast, by Form (2021-2033)

13.2.12.4. Market Revenue and Volume Forecast, by End-use (2021-2033)

13.2.13. Market Revenue and Volume Forecast, by Usage (2021-2033)

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Volume Forecast, by Product (2021-2033)

13.2.14.2. Market Revenue and Volume Forecast, by Sterility (2021-2033)

13.2.14.3. Market Revenue and Volume Forecast, by Form (2021-2033)

13.2.14.4. Market Revenue and Volume Forecast, by End-use (2021-2033)

13.2.15. Market Revenue and Volume Forecast, by Usage (2021-2033)

13.3. APAC

13.3.1. Market Revenue and Volume Forecast, by Product (2021-2033)

13.3.2. Market Revenue and Volume Forecast, by Sterility (2021-2033)

13.3.3. Market Revenue and Volume Forecast, by Form (2021-2033)

13.3.4. Market Revenue and Volume Forecast, by End-use (2021-2033)

13.3.5. Market Revenue and Volume Forecast, by Usage (2021-2033)

13.3.6. India

13.3.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)

13.3.6.2. Market Revenue and Volume Forecast, by Sterility (2021-2033)

13.3.6.3. Market Revenue and Volume Forecast, by Form (2021-2033)

13.3.6.4. Market Revenue and Volume Forecast, by End-use (2021-2033)

13.3.7. Market Revenue and Volume Forecast, by Usage (2021-2033)

13.3.8. China

13.3.8.1. Market Revenue and Volume Forecast, by Product (2021-2033)

13.3.8.2. Market Revenue and Volume Forecast, by Sterility (2021-2033)

13.3.8.3. Market Revenue and Volume Forecast, by Form (2021-2033)

13.3.8.4. Market Revenue and Volume Forecast, by End-use (2021-2033)

13.3.9. Market Revenue and Volume Forecast, by Usage (2021-2033)

13.3.10. Japan

13.3.10.1. Market Revenue and Volume Forecast, by Product (2021-2033)

13.3.10.2. Market Revenue and Volume Forecast, by Sterility (2021-2033)

13.3.10.3. Market Revenue and Volume Forecast, by Form (2021-2033)

13.3.10.4. Market Revenue and Volume Forecast, by End-use (2021-2033)

13.3.10.5. Market Revenue and Volume Forecast, by Usage (2021-2033)

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Volume Forecast, by Product (2021-2033)

13.3.11.2. Market Revenue and Volume Forecast, by Sterility (2021-2033)

13.3.11.3. Market Revenue and Volume Forecast, by Form (2021-2033)

13.3.11.4. Market Revenue and Volume Forecast, by End-use (2021-2033)

13.3.11.5. Market Revenue and Volume Forecast, by Usage (2021-2033)

13.4. MEA

13.4.1. Market Revenue and Volume Forecast, by Product (2021-2033)

13.4.2. Market Revenue and Volume Forecast, by Sterility (2021-2033)

13.4.3. Market Revenue and Volume Forecast, by Form (2021-2033)

13.4.4. Market Revenue and Volume Forecast, by End-use (2021-2033)

13.4.5. Market Revenue and Volume Forecast, by Usage (2021-2033)

13.4.6. GCC

13.4.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)

13.4.6.2. Market Revenue and Volume Forecast, by Sterility (2021-2033)

13.4.6.3. Market Revenue and Volume Forecast, by Form (2021-2033)

13.4.6.4. Market Revenue and Volume Forecast, by End-use (2021-2033)

13.4.7. Market Revenue and Volume Forecast, by Usage (2021-2033)

13.4.8. North Africa

13.4.8.1. Market Revenue and Volume Forecast, by Product (2021-2033)

13.4.8.2. Market Revenue and Volume Forecast, by Sterility (2021-2033)

13.4.8.3. Market Revenue and Volume Forecast, by Form (2021-2033)

13.4.8.4. Market Revenue and Volume Forecast, by End-use (2021-2033)

13.4.9. Market Revenue and Volume Forecast, by Usage (2021-2033)

13.4.10. South Africa

13.4.10.1. Market Revenue and Volume Forecast, by Product (2021-2033)

13.4.10.2. Market Revenue and Volume Forecast, by Sterility (2021-2033)

13.4.10.3. Market Revenue and Volume Forecast, by Form (2021-2033)

13.4.10.4. Market Revenue and Volume Forecast, by End-use (2021-2033)

13.4.10.5. Market Revenue and Volume Forecast, by Usage (2021-2033)

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Volume Forecast, by Product (2021-2033)

13.4.11.2. Market Revenue and Volume Forecast, by Sterility (2021-2033)

13.4.11.3. Market Revenue and Volume Forecast, by Form (2021-2033)

13.4.11.4. Market Revenue and Volume Forecast, by End-use (2021-2033)

13.4.11.5. Market Revenue and Volume Forecast, by Usage (2021-2033)

13.5. Latin America

13.5.1. Market Revenue and Volume Forecast, by Product (2021-2033)

13.5.2. Market Revenue and Volume Forecast, by Sterility (2021-2033)

13.5.3. Market Revenue and Volume Forecast, by Form (2021-2033)

13.5.4. Market Revenue and Volume Forecast, by End-use (2021-2033)

13.5.5. Market Revenue and Volume Forecast, by Usage (2021-2033)

13.5.6. Brazil

13.5.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)

13.5.6.2. Market Revenue and Volume Forecast, by Sterility (2021-2033)

13.5.6.3. Market Revenue and Volume Forecast, by Form (2021-2033)

13.5.6.4. Market Revenue and Volume Forecast, by End-use (2021-2033)

13.5.7. Market Revenue and Volume Forecast, by Usage (2021-2033)

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Volume Forecast, by Product (2021-2033)

13.5.8.2. Market Revenue and Volume Forecast, by Sterility (2021-2033)

13.5.8.3. Market Revenue and Volume Forecast, by Form (2021-2033)

13.5.8.4. Market Revenue and Volume Forecast, by End-use (2021-2033)

13.5.8.5. Market Revenue and Volume Forecast, by Usage (2021-2033)

Chapter 14. Company Profiles

14.1. Cardinal Health Inc.

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. MRK Healthcare Pvt. Ltd.

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Sempermed

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Globus Group

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Kanam Latex Industries Pvt. Ltd.

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Narang Medical Limited

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Hartalega Holdings

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Top Glove Corporation

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Ansell Ltd.

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. Sun Healthcare (M) Sdn. Bhd

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

PROCEED TO BUY :

   USD 5400
   USD 3800
   USD 2100
   USD 2100
   USD 7500

ASK FOR SAMPLE

No cookie-cutter, only authentic analysis – take the 1st step to become an Precedence Research client

Get a Sample